Comparative Analysis of Infarct-Limiting Activity of Peptide and Non-Peptide δ- and κ-Opioid Receptor Agonists during Heart Reperfusion In Vivo

A. V. Mukhomedzyanov,S. V. Popov,A. S. Gorbunov,N. V. Naryzhnaya,V. N. Azev,V. V. Kolpakov,E. A. Tomilova,E. V. Sapozhenkova,L. N. Maslov

DOI: https://doi.org/10.1007/s10517-024-06020-3

IF: 0.737

2024-02-11

Bulletin of Experimental Biology and Medicine

Abstract:A comparative analysis of the infarct-limiting activity of δ- and κ-opioid receptors (OR) agonists was carried out on a model of coronary occlusion (45 min) and reperfusion (120 min) in male Wistar rats. We used selective δ 2 -OR agonist deltorphin II (0.12 mg/kg), δ-OR agonists BW373U86 and p-Cl-Phe DPDPE (0.1 and 1 mg/kg), selective agonists of δ 1 -OR DPDPE (0.1 and 0.969 mg/kg), κ 1 -OR U-50,488 (0.1 and 1 mg/kg), κ 2 -OR GR-89696 (0.1 mg/kg), and κ-OR ICI-199,441 (0.1 mg/kg). All drugs were administered intravenously 5 min before reperfusion. Deltorphin II, BW373U86 (1 mg/kg), p-Cl-Phe DPDPE (1 mg/kg), U-50,488 (1 mg/kg), and ICI-199,441 had a cardioprotective effect. The most promising compounds for drug development are ICI-199,441 and deltorphin II.

medicine, research & experimental